The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has contributed to the Annuals by selecting critically from each year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is misleading.

Key Features

  • Provides a critical yearly survey of new data and trends
  • Includes an essay that describes the modern approach to classifying adverse drug reactions
  • Special reviews in this Annual include, among other topics: Antipsychotic drugs and now-onset diabetes mellitus, Treating asthma during pregnancy, and MMR vaccine and autism


Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, Clinical pharmacologists, and medical libraries

Table of Contents

Contributors Special Reviews Cumulative Index of Special Reviews, Annuals 14 – 28 DoTS Classification of Adverse Drug Reactions How to use this book ESSAYS: Data Mining in Drug Safety Central nervous system stimulants and drugs that suppress appetite Antidepressant drugs Lithium Drugs of abuse Hypnotics and sedatives Antipsychotic drugs Antiepileptic drugs Opioid analgesics and narcotic antagonists Anti-inflammatory and antipyretic analgesics and drugs used in gout General anesthetics and therapeutic gases Local anesthetics Neuromuscular blocking agents and skeletal muscle relaxants Drugs that affect autonomic functions or the extrapyramidal system Dermatological drugs, topical agents and cosmetics Antihistamines (H1 receptor antagonists) Drugs acting on the respiratory tract Positive inotropic drugs and drugs used in dysrhythmias Beta-adrenoceptor antagonists and antianginal drugs Drugs acting on the cerebral and peripheral circulations Antihypertensive drugs Diuretics Metals Metal antagonists Antiseptic drugs and disinfectants Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines Miscellaneous antibacterial drugs Antifungal drugs Antiprozotoal Drugs Antiviral drugs Drugs used in tuberculosis and leprosy Antihelminthic drugs Vaccines Blood, blood components, plasma and plasma products Formulations used in nutrition Drugs affecting blood coagulation, fibrinolysis, and hemostasis Gastrointes


No. of pages:
© 2007
Elsevier Science
eBook ISBN:
Print ISBN:
Print ISBN:

About the editor

Jeffrey K. Aronson

Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.

Affiliations and Expertise

Department of Primary Health Care, University of Oxford, Oxford, UK